ExactScience screenshot

ExactScience

HealthcareFree

Transforming Cancer Care Through Personalized Diagnostics

Last updated Apr 18, 2026

Claim Tool

What is ExactScience?

Exact Sciences Corp. is a leading molecular diagnostics company focused on transforming cancer care through prevention, early detection, and treatment guidance. Their cutting-edge product portfolio includes non-invasive screening tests like Cologuard® for colorectal cancer, Oncotype DX® for predicting cancer recurrence, and OncoExTra® for genomic profiling. The company also offers Riskguard™ for hereditary cancer risk assessment and is pioneering multi-cancer early detection tests. Committed to innovation and scientific validation, Exact Sciences plays a pivotal role in cancer diagnostics, earning endorsements from clinical guidelines and continuous certification as a Great Place to Work®.

ExactScience's Top Features

Key capabilities that make ExactScience stand out.

Comprehensive suite of cancer tests across the care continuum, including early detection and screening.

Offers Cologuard®, a non-invasive at-home stool DNA test for colorectal cancer screening.

Develops blood tests like Oncoguard® Liver for early detection of hepatocellular carcinoma and Riskguard™ for hereditary cancer risk assessment.

Provides advanced tests still in development, such as Cancerguard™ for multiple cancer detection.

Treatment guidance through tests like Oncotype DX Breast and Colon Recurrence Scores for assessing cancer recurrence and therapy benefits.

OncoExTra® test for aiding late-stage cancer therapy selection.

Supports patient and provider through logins for test ordering and results tracking.

Backed by extensive scientific research, publications, and clinical studies.

Engages in community outreach and health equity initiatives.

Use Cases

Who benefits most from this tool.

Healthcare providers

Utilize Cologuard® to screen patients for colorectal cancer in a non-invasive manner.

Oncologists

Guide treatment decisions for breast and colon cancer patients using Oncotype DX®.

Patients with liver conditions

Early detection of liver cancer with Oncoguard® Liver test.

Genetic counselors

Assess hereditary cancer risk with Riskguard™ for personalized patient guidance.

Cancer researchers

Explore opportunities in blood-based multi-cancer early detection technologies.

Healthcare administrators

Integrate Exact Sciences' tests into clinical workflows using ExactNexus™ technology.

Primary care physicians

Incorporate multi-cancer detection for preventive health measures.

Insurance companies

Evaluate coverage options for innovative cancer diagnostic tests.

Healthcare IT specialists

Facilitate seamless result reporting and electronic ordering processes.

Medical conference organizers

Showcase cutting-edge cancer diagnostic research and advancements.

Explore Top AI Use Cases

Tags

molecular diagnosticscancer carepreventionearly detectiontreatment guidancenon-invasive screening testscolorectal cancergenomic profilinghereditary cancer riskmulti-cancer early detectioninnovationscientific validationclinical guidelines

ExactScience's Pricing

Free plan available

Top ExactScience Alternatives

User Reviews

Share your thoughts

If you've used this product, share your thoughts with other builders

Recent reviews

Frequently Asked Questions

What is Cologuard®, and who is it for?
Cologuard® is a non-invasive, at-home stool test that screens for colorectal cancer in adults 45 years and older who are at average risk. It is a prescription-only test.
How does the Oncoguard® Liver test work, and what type of cancer does it detect?
The Oncoguard® Liver test is a blood test designed to detect hepatocellular carcinoma, the most common type of liver cancer, in individuals with cirrhosis or chronic hepatitis B. It uses a panel of DNA and protein markers for early-stage detection.
What cancers does the Riskguard™ test screen for, and what type of sample is needed?
Riskguard™ is a hereditary cancer test that screens for genetic changes associated with an increased risk of ten common cancers. A simple blood or saliva sample is required.
What is the Cancerguard™ test, and what stage of cancer does it aim to detect?
Cancerguard™ is a blood test under development that aims to detect multiple cancers in their earliest stages from a single blood draw.
What is Oncotype DX, and what types of cancer does it cover?
Oncotype DX is a suite of tumor-tissue tests providing treatment guidance, particularly for breast and colorectal cancers. It includes tests like the DCIS Score® and Recurrence Score®.
What is OncoExTra®, and for what type of cancer patients is it intended?
OncoExTra® is a genomic test analyzing both DNA and RNA from a tumor sample, tailored for patients with advanced, metastatic, or aggressive cancers.
What is the difference between screening and surveillance tests?
Screening tests, such as Cologuard®, are used to detect cancer before symptoms appear in individuals with average risk. Surveillance tests, like Oncoguard® Liver, are focused on finding cancer in high-risk individuals.
Are Exact Sciences' tests covered by insurance?
Many tests are covered by Medicare and various commercial insurance plans, but coverage can vary. It's advisable to check with your insurance provider.
What is the process for ordering and receiving results for Exact Sciences tests?
Tests can be ordered through the Exact Sciences website or a healthcare provider. Results are usually sent to the doctor, who will discuss them with the patient.
Where can I find more information about Exact Sciences' tests?
Detailed information is available on the Exact Sciences website, which includes test indications, results interpretation, and customer support contacts.